Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(2.47) per share. This is a 64.71 percent increase over losses of $(7.00) per share from the same period last year.
Boeing Misses Q3 Analyst Earnings Target, But 737 Production Target Takes Flight
Boeing Co (NYSE: BA)